Judy Foreman

Nationally Sindicated Fitness, Health, and Medicine Columnist

  • HOME
  • Books
  • BIO
  • BLOG
  • COLUMNS
  • Q&A
  • PRESS
  • CONTACT

Column Search

Column Categories

  • General Medicine
  • Women's issues
    • Breast Cancer
    • Hormone replacement
  • Cancer
  • Alternative Medicine
  • Nutrition
  • Exercise/Fitness
  • Heart Disease
  • Aging
  • Pain
  • Dental
  • Allergies
  • Mental Health
    • Depression
    • Alcohol
    • Loneliness/Loss
    • Sleep Problems
    • Anxiety

Herbal hazards taken alone or with prescription drugs, some of these innocent-sounding `natural’ remedies can be dangerous

October 26, 1998 by Judy Foreman

If your doctor suggested that you take two different sleeping pills that have never been tested in combination, would you do it?

If she recommended an energy-booster, but you couldn’t tell from the label what was in the bottle, would you take that?

What if she told you to ingest a medication normally used on the skin – would you want to know it might cause liver failure?

You’d probably answer “No,” “No way,” and “You bet your litigious soul I would.”

But now suppose you’re prowling the aisles in the health food store looking at “natural” remedies? You might grab something and figure, “Hey, this is herbal. It must be safe.”

As a nation, we’ve gone bonkers over alternative or “complementary” medicine, including “dietary supplements,” including herbs. More than one-third of American adults now use herbs and we spend more than $3.6 billion a year for them.

But like someone hopelessly in love, we’re a bit blind. Because herbs are sold – and regulated, by the Food and Drug Administration – as supplements, we don’t think of them as drugs, though we take them to fix or prevent all manner of ills.

This suits many people just fine, including Congress, which in 1994 curbed the FDA’s power to review supplements, including herbs, before they’re marketed.

But while the body politic may like things this way, the body into which we pour these products reacts the same whether something is labelled an herb or a drug. And while many herbs are apparently safe, some – and some combinations of herbs and prescription drugs – clearly are not. Consider:

In the latest of issue of FDA Consumer magazine, the FDA published a short list of herbs it considers “possible health hazards.” One is comfrey, whose leaf and root are used externally for treating bruises but which some people are ingesting for general healing. According to the FDA, which keeps track of adverse reports on herbs and supplements, comfrey can obstruct blood flow to the liver, with possibly fatal consequences.

Varro Tyler, dean emeritus of the Purdue University School of Pharmacy and Pharmacal Sciences, puts it bluntly: “Don’t drink comfrey. . . It should be taken off the market.”

Another risky herb is the stimulant ephedra (Ma huang), which can cause high blood pressure, heart attacks, stroke, and death.

Despite the 1994 law weakening its powers, the FDA still has the authority to yank supplements, including herbs, off the market if it can prove they’re dangerous. It hasn’t done so yet with any supplement, but it’s come closest with ephedra. Last year, the agency proposed dose limits on the active ingredient in ephedra, but so far has not followed up.

Other herbs the FDA lists as dangerous include chaparral, an underground “cure” for cancer that may cause irreversible liver disease; germander, an appetite suppressant that may also cause fatal liver disease; and dieter’s teas that can cause vomiting, constipation, and possibly death.

The FDA is also worried about willow bark, which is marketed as an aspirin-free product but can cause Reye’s syndrome, a potentially fatal disease associated with aspirin use by children; and lobelia, an emetic used to induce vomiting, that may cause cause breathing problems, rapid heartbeat, and possibly coma and death.

Complicating things is the fact that many people take more than one herb simultaneously and combine herbals with prescription and over-the-counter drugs. These combinations pose serious risks, says plant medicine specialist Tyler, who detailed his concerns in September’s Prevention magazine.

For instance:

  • Blood thinners. Many herbals – notably garlic, ginkgo, ginger, and feverfew – reduce the ability of the blood to clot, which can help prevent heart attacks and strokes. But if taken with over-the-counter anticlotting drugs like aspirin or prescription drugs like Coumadin, you may bleed too easily. If you’re facing surgery, you should not only stop taking mainstream anticoagulants, but the botanicals as well.

  • Diuretics and laxatives. Some herbal laxatives such as senna, cascara sagrada, and aloe make you lose a lot of water and potassium. If you take these remedies for more than a few days, you may be at risk for cardiac arrhythmias. Combining these with diuretics – prescription drugs for high blood pressure – increases this risk. In fact, combining prescription digitalis with diuretics, including the herbals, could even be fatal, warns Timothy Maher, head of the division of pharmaceutical sciences at the Massachusetts College of Pharmacy.

  • Sedatives and sleeping pills. Studies show that one herbal sedative, kava, is safe and effective for anxiety and, indirectly, for insomnia; another herb, valerian, works well for many people, too. But there is little data on combining these herbs with each other or with prescription sedatives, antidepressants or alcohol.

For that reason, Tyler says, it’s safest not to mix them. But Dr. Michael Jenike, associate chief of psychiatry at Massachusetts General Hospital, says some people do combine kava with Prozac-like antidepressants. “So far,” he says, “there are no apparent adverse effects, but there may be some risks we don’t know about.”

Combining kava with alcohol is risky, he says. You may become too sedated, as if you combined Valium and alcohol.

  • Substances that affect blood sugar. Hundreds of herbals, including bitter melon, dandelion, and prickly pear can lower blood sugar. In theory, if you combine these with insulin, you could wind up with too low blood sugar, which can lead to coma and death. This is less likely if you monitor blood sugar closely.

  • Antidepressants. Some people combine the herbal antidepressant St. John’s wort with prescription antidepressants like Prozac. Some people also use St. John’s wort with a diet drug called phentermine, an amphetamine-like stimulant. While the first combination may not be dangerous, the second, at least in theory, could be.

Like other so-called SSRI antidepressants, Prozac works by blocking reabsorption of serotonin, a neurotransmitter, by brain cells. Phentermine may increase serotonin in the blood by blocking its destruction in platelets, says Dr. Richard Wurtman, director of the MIT clinical research center and developer of Redux, a diet drug now off the market.

Last year, when the diet drug combination “fen/phen” was withdrawn from the market because of the risk of heart disease, some dieters switched to “phen-Pro,” a combination of Prozac and phentermine.

But the net effect of taking either fen-phen or phen-Pro may be the same – too much serotonin. That is believed to cause heart damage and a potentially fatal condition called primary pulmonary hypertension, says pharmacist Maher. He, with Wurtman, has shown that phentermine acts in the test tube like a class of drugs called MAO inhibitors, which boost a number of brain chemicals, including serotonin.

“If phentermine really is an MAO inhibitor, it would be potentially fatal to take with Prozac,” says MGH’s Jenike, and in theory that would hold for combining phentermine with St. John’s wort, too. So far, though, he is not convinced that phentermine is really an MAO inhibitor.

And what if St. John’s wort itself acts as both an MAO inhibitor and Prozac-like SSRI? That’s a possibility, says pharmacist Maher. If it’s true, that could make it dangerous to take with drugs like Prozac, Zoloft and Paxil and Effexor. But if St. John’s wort does act as an MAO inhibitor, “one would expect reports of adverse effects if you combined it with these prescription SSRIs,” says Jenike. So far, there have been none.

The bottom line is buyer beware. To the federal regulatory system, there’s a difference between herbs and drugs.

But to your body, there isn’t.

Supplement standards being written

Not long ago, the FDA had the power to force manufacturers of dietary supplements, including herbal remedies, to prove those products were safe.

That changed in 1994, when Congress passed the Dietary Supplement Health and Education Act.

Now a “dietary” product can remain on the market unless the FDA finds clear evidence – not mere suspicion – of harm, which means “people have to be hurt first,” says Bruce Silverglade, director of legal affairs for the Center for Science in the Public Interest, a nonprofit consumer group in Washington.

Also, the law only requires manufacturers to produce supplements in accordance with “good manufacturing practices” in the food industry. Manufacturing standards in the food industry are less stringent than those in the pharmaceutical industry. The FDA is now writing new standards for supplements.

Furthermore, before the law, all health claims on supplements – as on food – had to have FDA approval before marketing. Now, manufacturers can make “structure/function” claims without prior approval. That means they can’t say a product prevents heart disease, but they can say something vague, such as, this product “helps maintain cardiovascular function.”

The herbal industry is aware there have been quality-control problems, says Mark Blumenthal, executive director of the American Botanical Council, a nonprofit educational group based in Austin, Texas.

In fact, the council has developed a chemical analysis system to test products, he says. In one study using this system, the council found that some products that claimed to contain ginseng did not.

In August, the Los Angeles Times reported on a chemical analysis it commissioned on the herbal antidepressant, St. John’s wort: Three of 10 brands tested had no more than half the potency listed on the label, and four had less than 90 percent.

At least two companies are now beginning to analyze the ingredients listed on herbal products.

But sometimes, the problem is that herbal remedies contain adulterants that shouldn’t be there at all. In a recent issue of the New England Journal of Medicine, FDA researchers reported on two cases of serious heart problems traced to supplements contaminated with the powerful heart drug digitalis.

New therapy for trauma is doubted

September 14, 1998 by Judy Foreman

Eleven years ago, Francine Shapiro, was strolling through a park in Los Gatos, Calif., thinking dark thoughts.

Suddenly, her eyes started darting back and forth, a spontaneous burst of what scientists call saccadic movement, much like the rapid eye movements that occur during dreams.

Weirder yet, Shapiro noticed that as her eyes moved, her thoughts lightened. She played with the phenomenon — calling up disturbing thoughts, then flicking her eyes back and forth. Soon, bad thoughts no longer “had the same charge,” she says.

She was intrigued and began waggling her fingers in front of friends to trigger rapid eye movements, and they, too, reported mood changes.

Perhaps, Shapiro reasoned, the eye movements were somehow mimicking dream sleep, allowing better processing of traumas that might otherwise cause nightmares. Or maybe the eye movements triggered some useful shift in brain processing.

To this day, neither Shapiro nor anyone else can explain what, if anything, happens inside the brain with the technique she has dubbed EMDR — eye movement desensitization disorder, which, as Shapiro initially conceived it, involves inducing rapid eye movements while reliving painful memories.

But since that day 11 years ago Shapiro has been ferociously studying — and promoting — EMDR. When she first began her studies, she was enrolled in a now-defunct, never-accredited school, the Professional School of Psychological Studies in San Diego. She eventually earned a PhD in psychology there and in 1989 published a study showing EMDR seemed to help people with post-traumatic stress disorder, which is characterized by nightmares, flashbacks and anxiety.

More recent EMDR studies in people with emotional trauma, Shapiro claims, show that “84-90 percent no longer have post-traumatic stress disorder after only three treatments.”

Surely one of the strangest therapies ever aimed at tortured psyches, EMDR has become increasingly popular — and controversial. Shapiro has now trained more than 25,000 practitioners through the EMDR Institute in Pacific Grove, Calif., and estimates 2 million people have been treated.

Indeed, EMDR is “among the fastest growing interventions in the annals of psychotherapy,” says Harvard psychologist Richard McNally. But he cautions: “What is effective in EMDR is not new, and what is new is not effective.” Many others agree.

Yet EMDR has obvious appeal, especially to health insurers.

This spring, the Kaiser Permanente medical center in northern California began offering EMDR, calculating it could save $2.8 million a year if it was used for all post-traumatic stress disorder patients, says Steven Marcus, a Kaiser psychologist whose 1997 study led to the decision.

Other insurers also offer it, says Shapiro. And Blue Cross Blue Shield in Massachusetts is informally looking into it.

But two huge questions loom: Does it work, and if so, how?

Last year, a task force of the American Psychological Association headed by Dianne Chambless, a University of North Carolina psychologist, proclaimed EMDR a “probably efficacious treatment for civilian PTSD.” That means it’s not a “well-established” treatment, she says, but that at least two “scientifically sound” studies — three, by her count — showed EMDR “was more effective than no treatment.”

The so-called Wilson study of 1995, the Rothbaum study of 1997 and the Scheck study of 1998 all found that EMDR patients improved more than patients on a waiting list to begin therapy or those receiving standard talk therapy. In the Rothbaum study of 21 rape victims, in fact, 91 percent of the group treated with EMDR was deemed to have recovered from the trauma disorder after three sessions, while there was no change in the control group.

But if EMDR worked, was it due just to “imaginal exposure,” that is, to reliving in the imagination the traumatic event until it loses its power — like watching a horror movie so often you become desensitized? Or was it some almost magical effect from the therapist waggling her fingers to trigger the eye movements?

Dr. Roger Pitman, a Harvard psychiatrist and coordinator of research at the Veterans Affairs Medical Center in Manchester, N.H., decided to find out. In research published in 1996, Pitman studied 17 Vietnam veterans with PTSD. (Vets with the disorder are considered harder to treat than rape victims dealing with one assault.)

Pitman gave half the group EMDR, complete with finger-wagging and eye movements, and the other half a similar treatment without eye movements. Each group then got the other treatment. “EMDR had some benefit,” Pitman says, but “whatever it was, it wasn’t the eye movements.”

Grant Devilly, a psychologist at the University of Queensland in Australia who has two studies about to be published in scientific journals, agrees.

Starting with a group of 51 war veterans, Devilly gave some vets two sessions of EMDR, others, no special treatment, and a third group, “sham” EMDR. This group relived traumatic memories, but their eyes remained fixed on a flashing light from an “opticator,” a phony machine designed to look scientific.

Both the real and sham EMDR groups showed some improvement, but it was not statistically signficant. And there was no difference between those whose eyes moved and those whose eyes didn’t, says Devilly. Conclusion: The eye movements are not essential.

In the other study, Devilly compared EMDR to cognitive behavior therapy, in which patients relive their trauma and learn ways to deal with it. Both helped, he says, but cognitive behavior therapy was better and longer lasting, though EMDR guru Shapiro claims other new studies still give EMDR the edge.

Other critics of EMDR, like Jeffrey Lohr, a psychology professor at the University of Arkansas, remain underwhelmed.

Writing in a 1997 newsletter of the National Council Against Health Fraud, Lohr and a co-author charged that Shapiro “took existing elements from cognitive-behavior therapies, added the unnecessary ingredient of finger waving, and then took the new techique on the road before science could catch up.”

But Dr. Bessel van der Kolk, a Boston University psychiatrist and head of the medical trauma center at Arbour Health Systems, a private organization in Brookline, disagrees.

Initially skeptical, van der Kolk, a specialist in post traumatic stress disorder, says he became convinced when his patients sought EMDR elsewhere and came back saying it helped more “than five years of talking therapy.” When that happens, he says, “you start sitting up.”

So far, he has studied 12 people with PTSD and is now analyzing brain scans before and after EMDR treatment. EMDR is “pretty bizarre,” he acknowledges, but it seems to have induced “remarkable changes” in some people.

For her part, Shapiro has softened her view that eye movements are essential. Part of what changed her mind was that anecdotal evidence from blind patients for whom therapists used tones and hand-snapping instead of finger-wagging and produced results similar to standard EMDR.

She bristles at charges that she has tried to keep data that conflict with her findings from being published, arguing her critics are waging “ad hominem” attacks on her.

But the critics aren’t backing off. As Lohr puts it: “EMDR is cognitive behavior therapy with bells and whistles that won’t do anything. It’s a dog that won’t hunt.”

SIDEBAR:

Troubles on the right

Eye movements may play a role in a new treatment for anxiety developed by Dr. Fredric Schiffer, a psychiatrist at Harvard’s McLean Hospital in Belmont.

Schiffer believes people may literally be of two minds: A person may feel anxious when one side of the brain is dominant, but calm and mature when the other side holds sway — almost as if the “inner child” lived on one side and the adult self on the other. By using special goggles that feed visual input to one side of the brain at a time, Schiffer thinks, it may be possible to shift back and forth between these states.

More than 30 years ago, researchers led by 1981 Nobel laureate Roger Sperry began studying “split brain” patients, people with severe epilepsy that doctors treated by cutting the nerves that connect the left brain hemisphere to the right.

The researchers found the two halves of the brain could process information independently. In the popular imagination, this helped fuel the (wildly oversimplified) notion that logic resides in the left brain and emotions on the right.

Two years ago, Schiffer studied a split-brain patient who’d been bullied as a child, and he found that the patient denied distress when his left brain was activated, but expressed it when the right side was.

Schiffer has devised goggles that control visual input to the brain and tested them in 70 patients. About 60 percent reported some difference in anxiety depending on which side of the brain was stimulated; 30 percent report clinically significant differences.

The goal, says Schiffer, whose book, “Of Two Minds,” hit stores this month, is “to teach the troubled side of the brain that the world is less threatening that it thought.”

Ginkgo stock is continues to rise

August 10, 1998 by Judy Foreman

Like many others at midlife or beyond, Wendy Fink, a health educator in her 50s, was appalled at the way her memory kept conking out.

“I was having trouble getting words,” says Fink, who lives in Royalston. “I was feeling very stressed about this.” So she tried ginkgo, an herbal memory-booster that’s getting new respect in mainstream medicine, albeit for genuine dementia, not run-of-the-mill “senior moments.”

“It seems simplistic,” Fink says of her four-month trial of ginkgo last winter, “but my problem went away. I feel much clearer, brighter, more myself.” She has “no idea,” she adds, why the improvement has persisted although she no longer takes the ginkgo.

The fact that she can’t explain it is hardly surprising, given that there’s little evidence that ginkgo helps healthy people like Fink with age-related memory decline.

But the lack of evidence doesn’t seem to be deterring the hopeful, who last year spent $ 270 million on ginkgo, making it the third best-selling herbal remedy, after echinecea, the cold-fighter, and ginseng, the energy-booster.

Sales “took off” last fall, among both healthy folks and those with dementia, after the Journal of the American Medical Association published a study showing it improves mental functioning in people with dementia, says Thomas Aarts, executive editor of the Nutrition Business Journal in San Diego.

Even the government is intrigued. The National Institute on Aging and the Office of Alternative Medicine are jointly sponsoring a two-year study in 42 patients with Alzheimer’s disease at Oregon Health Sciences University.

The ginkgo tree responsible for all this is a natural wonder. It’s so ancient – its ancesters appeared 300 million years ago – it’s known as a “living fossil. And it’s so resistant to environmental toxins that it thrives in smoggy cities worldwide. And therein may lie its secrets.

The tree’s resistance to insects and toxins may stem from its chemical makeup, says Varro Tyler, a plant medicine specialist emeritus at Purdue University and co-author of “Rational Phytotherapy, a Physicians’ Guide to Herbal Medicine.”

Its two main constituents are the flavonoids, which gobble up free radicals (harmful byproducts of oxygen metabolism), and the ginkgolides, which inhibit a natural platelet activating factor and therefore make the blood less likely to form clots that can clog arteries.

Ginkgolides are devilishly complicated molecules. In fact, Harvard chemist Elias J. Corey, who won the 1990 Nobel Prize for developing a method to synthesize complex organic molecules, including ginkgolide B, recalls that he became interested in the ginkgo molecule precisely “because it was such a challenge.”

Because ginkgo seems to boost blood flow and combat free radicals, the German Commission E, a government-appointed panel that reviews herbal therapies, recommended it in 1994 for dementia-related memory deficits, dizziness, ringing in the ears.

Ginkgo may also help alleviate impotence caused by anti-depressant drugs, according to Tyler.

So far, there have been more than 100 studies on ginkgo by plant medicine scholars, including 36 German studies in the 1980s in which patients with declining intellectual function appeared to benefit from 120 to 160 milligrams a day of ginkgo extracts. German authorities later criticized these studies for not including measurements of daily functioning as well as symptoms of disease progression.

But two recent studies did include those measures. In 1996, a Berlin study of 156 patients with Alzheimer’s disease or stroke-related dementia showed that a particular ginkgo biloba extract called EGb761 was a modestly effective and safe treatment, at a relatively high dose of 240 mg a day.

Last year, in the JAMA study of 202 dementia patients that sent American sales soaring, Dr. Pierre L. Le Bars, executive research director at the New York Institute of Medical Research in Tarrytown, also found that extract modestly effective.

About 27 percent of patients responded to ginkgo, Le Bar says, about the same response rate that occurs with a prescription drug called Cognex and less than the 40 to 50 percent response rate to another prescription drug, Aricept.

Compared to a placebo or dummy drug, a relatively low dose of ginkgo (120 mg a day) is linked to slight improvements in intellectual function, social behavior, and mood, Le Bars found.

In other words, ginkgo is promising, but not dazzling.

In fact, the effects of ginkgo are “so minuscule that. . .they may mean little from a functional point of view,” adds Dr. Thomas Perls, a geriatrician at Beth Israel Deaconess Medical Center. “Ginkgo is barking up the right tree. I just don’t know if it’s the right dog.”

Still, it’s being taken ever more seriously by researchers.

Jerry Cott, head of adult psychopharmacology research at the National Institute of Mental Health, says ginkgo has been shown in test tubes to protect neurons. And data suggest, he says, that ginkgo “is potentially more effective than vitamin E,” which in high doses can slow progression of dementia symptoms.

But there’s no evidence yet that ginkgo can actually prevent Alzheimer’s, “and that’s where we really need the answer,” adds Cott, who is helping the World Health Organization design a study to find out.

Marilyn Albert, director of gerontology research at Massachusetts General Hospital, agrees: “I’d be cautious, because the government does not oversee manufacturing of ginkgo and other products sold as dietary supplements. And this drug, like any other, might potentially interact with other medications.”

Still, barring reports of horrible side effects, the appeal of ginkgo is likely to continue to grow. So if you want to try it, start with 60 to 180 mg a day in divided doses, suggests Barry Taylor, a naturopathic doctor at the New England Family Health Center in Weston who says he’s recommended ginkgo to “hundreds” of patients.

But make sure the label says the capsules contain roughly 24 percent ginkgo flavonoids (also called flavonone glycosides) and 6 percent terpene lactones (also called ginkgolides A, B and C and bilobalide, a related compound.)

Discontinue ginkgo if you get a rash or other allergy. And because ginkgo can make blood less likely to clot, don’t take it without consulting your doctor if you have a bleeding disorder or take blood-thinning drugs, including aspirin.

Kava root is hot herb for anxiety

June 15, 1998 by Judy Foreman

Traditionally, whenever the people of the South Pacific islands wanted to welcome a visitor or provide a social lubricant for communal rituals, they drank a potent potion made from the roots of an intoxicating pepper plant, kava kava.

The jaw-breaking job of turning the tough root of the piper methysticum into homemade brew fell to young virgins — male or female, depending on the island — who spent hours chewing the root, then spitting out the masticated mush into a communal pot, where it was left to mature for several hours before being quaffed.

The effects, says herbal “medicine hunter” and kava promoter Chris Kilham of Lincoln, were nearly instantaneous: a feeling of profound well-being and relaxation.

What more could one ask? Okay, maybe a little scientific validation. And access.

Westerners are beginning to get both. In fact, although there are other herbs that are said to allay anxiety, it’s kava that seems poised to take off like St. John’s Wort, the herbal antidepressant that was virtually unheard of a couple of years ago in this country and now commands $200 million a year in sales.

“The kava market has come out of nowhere. It’s gone from next to nothing to $40 to $50 million in sales in one year,” says Thomas Aarts, executive editor of the Nutrition Business Journal in San Diego. At that, it’s still a small chunk of the booming business in dietary supplements, which has grown 14 percent a year for the last three years to $11.5 billion now, driven in part by the popularity of herbals.

“Kava is a hot herb,” agrees Matthew Patsky, a stock analyst who specializes in the natural food and nutrition industry for Adams, Harkness & Hill, a Boston investment bank. “It works great for me.”

Others say kava induces a state of relaxation without fogging the mind as some prescription tranquilizers can. Kava produces “a delightful feeling,” enthuses Kilham, who consults for herbal products companies that import or market kava.

Since many things that sound too good to be true are, some caveats: The scientific evidence on the benefits and possible risks of kava is still limited. There have been 38 double-blind, placebo-controlled studies on St. John’s Wort, also known as hypericum, says Dr. Harold Bloomfield, a California psychiatrist who has written a book on it.

By comparison, there are only a half dozen decent studies on kava, he says. “We need many, many more — this is preliminary research at best.”

Dr. Steven E. Hyman, director of the National Institute of Mental Health, agrees, calling the kava data “quite weak.” But NIMH is intrigued enough that it may fund research on it.

If the research is not yet there, the need is: An estimated 23 million Americans wrestle with crippling, life-wrecking, chronic anxiety, and millions more suffer milder forms.

Granted, there are mainstream treatments available, including anti-anxiety drugs like Valium, Xanax and Klonopin, which are often effective but can cause cause physical dependence. Non-habit forming drugs like Prozac, an anti-depresssant, also work against anxiety, as does cognitive-behavior therapy and other “talking” psychotherapy.

Despite all this, there’s still enough angst out there that the potential demand for herbal tranquilizers is huge.

You should, of course, consult your doctor before self-medicating for severe anxiety — or any other serious medical problem. But if you decide to try kava, here’s what you need to know.

The active ingredients in kava go by two interchangeable names: kavalactones or kavapyrones. Check the label — it should say each capsule is “standardized” to roughly 75 milligrams of kavalactones or kavapyrones, meaning the concentration is consistent from batch to batch. (Note: Kava pills come in varying strengths — from 100 to 250 mg — and the percentage of kavalactones also varies. A 250-mg capsule of 30 percent extract would contain 75 mg of kavalactones.)

The German Commission E, a government-appointed panel that reviews herbal remedies, has approved kava to combat anxiety, stress and restlessness and recommends a dose of 60 to 120 milligrams a day of kavapyrones.

Gail Mahady, a pharmacist and plant medicine specialist at the University of Illinois, adds that side effects are apparently rare. A monograph she’s writing for the World Health Organization will endorse the use of kava for anxiety symptoms.

Some people are allergic to it, however, especially those with known allergies to pepper, and kava can cause a temporary yellowing of the skin if used too long. The German commission recommends using it for not more than three months and says pregnant or nursing women and people with serious depression should not take it at all.

For many people, though, kava appears to be both safe and effective at the recommended doses, says Varro Tyler, a plant medicine specialist emeritus at Purdue University.

In fact, six carefully-done studies of kava extracts, all done in Germany since 1989, show kava is “quite satisfactory” when compared to a placebo or a prescription anti-anxiety drug such as oxazepam (Serax), Tyler adds.

Kava is not only a potent muscle relaxant, it also acts, just as alcohol and prescription anti-anxiety drugs do, on so-called GABA receptors in the brain, which regulate anxiety. Kava may also quiet a brain region, the amygdala, which also governs anxiety.

So far, there’s “no evidence of physical or psychological dependence,” adds Dr. David Mischoulon, a psychiatrist and psychopharmacologist at Massachusetts General Hospital.

But even those sympathetic to herbal remedies urge caution, among them Dr. Laura Kramer, a psychiatrist at the American WholeHealth Arlington-Cambridge Center.

Unless your doctor advises otherwise, she says, you should not drive or operate machinery while taking kava because it may make you drowsy. Nor should you take it with other drugs that act on the central nervous system, including alcohol or prescription anti-anxiety drugs like benzodiazepines. At high doses, kava may cause intoxication.

“You have to treat kava as a medication — you have to respect it,” she says.

And start with low doses, about 70 to 85 mg of kavalactones, taken at night, says California psychiatrist Bloomfield. If that’s not enough, he says, take a second pill in the morning.

If, after a week, that is still not enough, you can add a third pill at midday. But once you’re feeling consistently more relaxed, taper down by one pill every few days.

And if, despite three pills a day, you’re still very anxious, don’t waste any more time. Call your doctor.

SIDEBAR 1:

For general information on anxiety, call:

  • 1-888-8-ANXIETY, National Institute of Mental Health information line, which will mail you a pamphlet. (You don’t have to dial the `y’ to get through.)
  • The Center for Anxiety and Related Disorders at Boston University: 617-353-9610.
  • Or you can contact the following organizations:
  • National Alliance for the Mentally Ill, 200 N. Glebe Road, Suite 1015, Arlington, Va. 22203-3754. Tel: 800-950-NAMI (950-6264).
  • Anxiety Disorders Association of America, Dept. A, 6000 Executive Boulevard, Suite 513, Rockville, MD 20852. Tel: 301-231-9350.
  • Freedom from Fear, 308 Seaview Ave., Staten Island, N.Y., 10305. Tel: 718-351-1717.
  • American Psychiatric Association, 1400 K Street NW, Washington, DC 20005. Tel: 202-682-6000.
  • American Psychological Association, 750 1st Street NE, Washington, DC 20002-4242. Tel: 202-336-5500 or 800-374-2721.
  • Association for Advancement of Behavior Therapy, 305 7th Avenue, New York, NY 10001. Tel: 212-647-1890.
  • National Mental Health Association, 1201 Prince Street, Alexandria, Va., 22314-2971. Tel: 800-969-6642.
  • National Mental Health Consumers’ Self-Help Clearinghouse, 1211 Chestnut Street, Philadelphia, Penn. 19107. Tel: 800-553-4539.

SIDEBAR 2:

Topical reading, for more information on herbal remedies for anxiety, you might read:

  • “Healing Anxiety with Herbs,” by Dr. Harold Bloomfield, HarperCollins.
  • “Rational Phytotherapy — A Physician’s Guide to Herbal Medicines,” by Volker Schulz, Varro E. Tyler, and Rudolf Hansel, Springer-Verlag N.Y.
  • “Kava — Medicine Hunting in Paradise,” by Chris Kilham, Park Street Press.

SIDEBAR 3:

Other herbs may ease anxiety.

Kava is currently the hottest herbal treatment for anxiety, but other plant medicines may also help. Before you experiment, though, talk to your doctor. Many herbs can cause allergic reactions. And don’t take multiple psychoactive drugs of any type — including alcohol and herbals — at the same time, unless a doctor says otherwise.

Among the herbs often used for anxiety are these:

  • Valerian. This herb has been used for more than 1,000 years as a minor tranquilizer and sleep inducer. Both the German Commission E and the World Health Organization have reviewed it and deemed it safe and effective. For insomnia, the suggested dose is 450 to 600 milligrams of valerian extract at bedtime. It may take two to four weeks before you see any effect.

Eight placebo-controlled, double-blind studies show valerian reduces the time it takes to fall asleep. Data also suggest that valerian improves mood and scores on a commonly-used anxiety rating scale. But the stuff smells awful, and doses vary. So read the labels and stick to the recommended doses.

  • St. John’s Wort. This herbal anti-depressant may also help with anxiety, says the German Commision E, though the data are skimpy. Unlike kava, which works right away, St. John’s Wort — taken as a 300 mg pill three times a day — takes two to four weeks to kick in. Dr. Harold Bloomfield, a California psychiatrist, often starts patients on kava for its immediate effects and adds St. John’s Wort, then tapers off kava as St. John’s Wort kicks in. St. John’s Wort can cause sun sensitivity.
  • Chamomile. The German Commission E and WHO approve this for nervous upset and mild insomnia — especially as a tea or extract. Though a 1994 study shows it contains apigenin, an anti-anxiety agent, it’s weaker than valerian and kava. People who are allergic to ragweed, chrysanthemums, and other plants in the daisy family should avoid it.
  • Passion Flower. Hops. Lavender. Lemon balm. All these herbs are approved by the German Commission E, but there’s little scientific data to support their use for anxiety.
  • Catnip. Pure folklore. There are few, if any, studies of its safety and efficacy. (Like valerian, catnip jazzes up cats but sedates people — for utterly mysterious reasons.)

Chiropractic makes gains vs. skeptics

June 23, 1997 by Judy Foreman

Arthur Borneman, a 74-year-old Quincy man, had a pain in the neck. He tried painkillers, months of therapy at a rehab hospital, massage, exercise, even a dental specialist in case the problem was jaw pain. 

To his surprise, the dentist urged him to see a chiropractor, but Borneman said he “had no faith in chiropractors.”

Still, figuring he had nothing to lose, Borneman went to Barry Freedman, a Quincy chiropractor who practices with his daughter, Gabrielle. Four weeks after his first visit, Borneman says, “I am much better. I feel like living again.”

Joan Doody, 33, a nurse from Needham who hurt her back lifting patients, offers a similar testimonial after seeing Michael Frustaci, a chiropractor in Wellesley and Brookline who quickly “adjusted” her spine and sent her happily on her way.

Despite many such stories from satisfied clients and some evidence that “back-cracking,” or spinal manipulation, is safe and effective for some types of back pain, chiropractic therapy is one of the most contentious of the alternative medicine practices now sweeping America.

There are still major grudges between chiropractors and doctors, several years after the chiropractors won a 16-year court battle to get the American Medical Association to stop trying to eliminate the chiropractic competition by refusing to refer patients or accept patients referred by chiropractors.

And there’s heated debate within the profession as well. Some, like Frustaci, think chiropractors should stick to manipulating the spine to ease sore backs and other musculo-skeletal problems. This is both “highly effective,” he says, and precisely what chiropractors learn in their specialized, four-year training.

Others, like Freedman, say that even though though they do not have M.D.degrees, most chiropractors “look at themselves as primary-care providers.They can diagnose whether the patient can benefit from chiropractic and/or whether they need a consultation from another doctor.”

And chiropractors still face criticism from many quarters, including the California-based National Council Against Health Fraud whose president, William Jarvis, a health education specialist, puts his criticism bluntly:

Chiropractic “is so bizarre, so dangerous and so bad that even when you just tell the straightforward truth about it, people think you are exaggerating.”

Even defining the basic concept of chiropractic is up for grabs — the notion that “subluxations,” or tiny misalignments of spinal vertebrae, are real phenomena that show up on X-rays, cause virtually all disease and can be forced back into aligment with a thrust of the hands.

This belief began with the founder of the movement, Daniel David Palmer, an Iowa grocer who more than 100 years ago claimed to cure a man of hearing loss by manipulating his spine. This is highly unlikely because the nerves for hearing all lie within the skull.

Furthermore, chiropractors have never been able to show that subluxations even exist, says Jarvis. No one has been able to correlate back pain with specific spinal misalignments, and many people with back pain have perfectly normal spinal X-rays, while some with abnormal X-rays have no pain.

The debate over subluxations has been so heated that, over a decade ago, chiropractor Ron Slaughter and like-minded souls founded their own group, the National Association for Chiropractic Medicine, to renounce what Slaughter calls “the historical, philosophical hypothesis that subluxation is the cause of all disease, which it surely is not.

“Subluxation is a metaphysical disease. . .and consequently, chiropractic today is practically a religion.”

Yet for all that, there’s no denying its popularity.

Last year, 22 million Americans went to a chiropractor, according to the

American Chiropractic Association, and half of all HMOs, or health maintenance organizations, now include a chiropractic benefit. In fact, despite lingering animosity, some doctors now refer patients to chiropractors, and most health insurers now cover the service, which runs about $35 a visit.

That’s partly because some research suggests spinal manipulation — a forceful thrust on the backbone — may help.

At RAND, a nonprofit think tank in Santa Monica, Calif., medical sociologist Ian Coulter and others conducted two meta-analyses in which they pooled data from various studies on manipulation for pain in the lower back and the neck.

Manipulation is defined as moving a joint to the limit of its range of motion and is often characterized by a popping sound, caused by escaping gases in the joint. Mobilization is moving the joint within its range of motion.

Although chiropractors helped fund the RAND study, the researchers focused on manipulation itself, not on who does it. In practice, chiropractors do the most spinal manipulations, but osteopaths (whose training is similar to that of M.D.s), physical therapists and others do, too.

The first RAND report, which became part of a 1994 report by the government’s Agency for Health Care Policy and Research, found positive but “not overwhelming” evidence that manipulation eases acute low back pain, says Coulter. There was was too little evidence to draw conclusions on chronic low back pain.

In a second report last year, the RAND team found that manipulation and mobilization both work for acute neck pain, though, again, the evidence on chronic pain was inconclusive. More recently, a Quebec study on whiplash and related injuries found that manipulation does seem to help with neck pain.

The RAND research also suggests that spinal manipulation is safe, says Coulter, with a “very low complication rate” — one in every one to two million adjustments.

Dr. Scott Haldeman, a chiropractor who is also a clinical neurologist at the University of California at Irvine Medical Center, concurs.

Haldeman acknowledges there is a small risk of stroke after manipulation because sudden twisting — even a quick turn of the head while driving or tipping the head back for a beauty salon shampoo — can injure arteries inside the vertebrae.

But this is “extraordinarily rare,” he says, and others note that it probably happens only to people who have a rare, hard to diagnose, anatomical abnormality. Still, Jarvis notes that over the years there have been reports of more than 100 strokes after spinal manipulation, and one recent California study, he says, found 56 strokes related to manipulation in just two years.

But Coulter says his team looked hard for examples of manipulation-related strokes and found very few.

It may also be dangerous to have any kind of manipulation too often, because ligaments along the spine may get stretched too far. And you should be wary of spinal manipulation if you have a suspected fracture, rheumatoid arthritis, severe osteoporosis, a bleeding disorder and any spinal infection or inflammation.

It’s still an open question whether chiropractic treatment, even with very gentle pressure, is appropriate for children.

Some say no, but Haldeman, whose father was a chiropractor, says he had his first adjustment “when I was a baby” and adds that he “treated my kids when they were young.”

In the end, it’s an individual decision whether to try chiropractic and if so, with whom. If you choose it, though, one rule of thumb is to steer clear of a chiropractor who says you need endless treatments.

In most cases, says Frustaci, people “don’t need more than six manipulations for any given episode of pain.” In fact, most bouts of back pain go away on their own in about four weeks.

You should also be skeptical of a chiropractor who tries to sell you vitamins, as some do, notes Haldeman.

And while Jerome McAndrews, spokesman for theAmerican Chiropractic Association, insists chiropractors “are trained in the full scope of diagnosis to the level of a general family practitioner,” others advise taking medical problems that are not obviously related to the spine to a physician.

Frustaci makes no bones about chiropractic’s limits: “My wife is a physician. There’s things I know I have no clue about, that my training doesn’t even come close to.”

You might also question a chiropractor who seems too eager to take X-rays.Although Medicare insists on X-rays to prove that “subluxation” is present, Frustaci says, this is odd, given the ongoing debate on whether subluxation even exists.

It is also a red flag if your practitioner has so much faith in chiropractic

that he or she advises you not to have your kids immunized against common childhood diseases.

As with so many other things, Jarvis says, it’s a case of “buyer beware.”

 

Herb found to aid mild depression

April 28, 1997 by Judy Foreman

Karin Taylor, 58, a tax accountant in Toronto, was stumped. She had a good  marriage, two “wonderful kids,” and a job she loved. 

“I had no reason whatsoever to feel depressed,” she says. “Yet there it  was.”

Sure, she was aware in the back of her mind of her family history of  depression, including three relatives who committed suicide. But she had always felt fine, until a year ago, when, for no obvious reason, life just  lost its zest.

She tried every self-help trick in the book – meditation, positive  thinking, creative visualization. Nothing worked.

Desperate, she finally saw a doctor and, putting aside her fear of side  effects, agreed to a prescription for Paxil, an antidepressant drug. But  she never took it.

Just as she was about to, a longtime woman friend came to visit, bringing along an herbal antidepressant called St. John’s wort, or Hypericum perforatum, which is sold as a dietary supplement.

Taylor tried it – three 300 milligram tablets a day – and now says she  feels “wonderful. I just feel completely natural – no highs, no lows. I  just feel the way I always recall feeling.”

Taylor’s woman friend swears by it, too, saying the herb “took away the underlying total  gray cloud” that had always been with her, despite 10 years of therapy,  12-step programs, exercise and a prescription antidepressant, Effexor,  which she still takes.

St. John’s Wort, or Johanniskraut, has become the antidepressant of choice  in Germany, where it outsells Prozac 7-to-1; in fact, it outsells all  other antidepressants combined.

It’s taking off here, too, says industry analyst Patricia Negron of Adams, Harkness & Hill in Boston. Sales began to grow last fall, she says, and  have “been building ever since.”

The herb “is probably going to be one of the biggest herbs of 1997,” says  Mark Blumenthal, executive director of the American Botanical Council, a Texas research and educational group. “It’s driven not by market hype but by clinical data.”

Many people with depression, of course, are successfully treated with “talk therapy,” prescription antidepressants or both. But as alternative medicine grows in popularity, it is perhaps no surprise that people are turning to herbal remedies for psychiatric as well as physical ills.

Often, mainstream American doctors scorn or ignore herbal remedies because they can’t find studies on the products’ safety or efficacy in medical  journals. With St. John’s wort, they can.

Last August, the British Medical Journal published a compilation of 23  randomized trials of the herb involving 1,757 patients with mild or  moderate depression. In 15 of the trials, some people were given the medication and others a dummy drug; in eight, people were given either the  herb or standard antidepressants.

Some of the studies were flawed – definitions of depression were not  always consistent with American definitions, for instance – but the  results were encouraging. They showed that the herb was “significantly superior to placebo” and “similarly effective as standard  antidepressants.”

Furthermore, side effects like upset stomach occurred in less than 20 percent of people taking the herbal remedy, compared to more than half of  those on standard antidepressants.

The October, 1994 issue of Geriatric Psychiatry and Neurology was devoted to data on the herbal antidepressant as well.

Promising as all this seems, there is a major problem: Nobody really understands quite how it works.

One theory that it acts like a type of prescription antidepressant called a monoamine oxidase inhibitor, or MAOI, has been discredited, easing  concerns that St. John’s wort users would have to avoid foods that react  badly with MAOIs.

But these findings leave wide open the question of how the herb does work.

For years, researchers assumed that the key ingredients are hypericin and  pseudohypericin, but these chemicals do not seem to cross the blood-brain barrier, a membrane that protects the brain. That raises the question of  how they can affect brain chemistry.

One possibility is that the chemicals may act on immune cells that then secrete chemicals that do cross the blood-brain barrier.

Others think the herb may increase brain levels of the neurotransmitter serotonin, as many prescription antidepressants do. If so, the key  ingredient may be turn out to be a third constituent, hyperforin.

Other theories are that the herb lowers levels of the stress hormone cortisol or that it acts on receptors called GABA on brain cells.

However it works, St. John’s wort is cheap – about $ 10 for a month’s supply in health food stores, compared to about $80 for a two-to-four-week supply of Prozac.

It also seems to have little toxicity, unlike some prescription antidepressants that can cause agitation, inhibition of sex drive, dry mouth, urinary retention and, in rare cases, abnormal bleeding.

The herb seems to help “with no side effects, really, for mild  depression,” says Dr. Michael Jenike, associate chief of psychiatry at  Massachusetts General Hospital. “I’m sure Prozac would come out ahead for any kind of moderate to severe depression. But for mild depression, St. John’s wort may be just as good.”

Dr. Harold H. Bloomfield, a psychiatrist in Del Mar, Calif., agrees, noting that the herb “is used by well over 20 million people” in Europe.

Because it is not clear how well, if at all, St. John’s wort works in more severe depression, most researchers warn that you should not even consider  it – or any do-it-yourself approach – if you are seriously depressed or  suicidal.

Instead, get to a psychiatrist or other licensed mental health professional who can assess your situation and offer treatment that’s already well-tested in this country.

And never take St. John’s wort along with any other psychoactive medication, warns Varro Tyler, a plant medicine specialist emeritus from Purdue University.

Jenike agrees. “Absolutely, you should not mix” this with other medications, “and I would be very careful with alcohol, too.” Mixing antidepressants, even mainstream prescription forms, can be fatal.

St. John’s wort has also been associated with sun sensitivity in animals,  which means users might be more sensitive to sunburn.

Despite such caveats, if you’re one of the millions of Americans like Taylor’s woman friend who have been slogging through life in a gray cloud, the herbal  antidepressant might help.

In fact, the National Institute of Mental Health and the Office of  Alternative Medicine are are excited enough about it that they are  planning to seek proposals from psychiatrists willing to study it.

“Everyone wants to apply,” says Jerry Cott, chief of the pharmacological  treatment research program at NIMH.

Taylor’s woman friend is already a convert. She used to think antidepressants of any  kind were “unnatural.” Now, she says, “it was the gray cloud I lived under  that was unnatural.”

People, and pets, touting arthritis remedy

April 7, 1997 by Judy Foreman

Dr. Margaret Slater, a veterinarian and epidemiologist at Texas A & M University, gives the stuff to all her loved ones, two-footed and four-footed, who suffer from arthritis.

“My dog, my horse, my mother and her dog are all benefitting from it,” she says with a chuckle.

Dr. David Hungerford, chief of orthopedics at the Good Samaritan Hospital in Baltimore, is waiting to see – and perhaps even conduct – a clinical study on the substance.

But meanwhile, this Johns Hopkins surgeon whose arthritic hands perform 300 joint replacement operations a year, many on people with arthritic knees, has begun taking the stuff himself.

“I’ve had significant improvement,” he says.

In Toronto, Dr. Joseph B. Houpt, director of rheumatology at Mt. Sinai Hospital, is already doing a study, prompted by enthusiastic reports from patients who buy the remedy in health food stores. And by watching his dog.

“I have two yellow Labs,” he says. “One was creaking and groaning, unable to jump over stumps, unable to jump up on the couch.” She’s been “like a pup” since she’s been on the drug.

Oops. We are not supposed to call this stuff a drug, no matter how much it sounds – or acts – like one. Officially, it’s a dietary supplement, actually two supplements called glucosamine and chondroitin sulfate, which are made naturally in the body and are found, in tiny quantities, in food.

The supplements have been selling briskly, thanks to high profile reports in the media and a best-selling book with a vastly over-hyped title.

Taken separately, the supplements appear safe, based on studies in Europe, and to protect against the cartilage destruction that is the hallmark of osteoarthritis, which affects 16 million Americans. Rheumatoid arthritis affects another 2 million.

Because they are sold as supplements, these products are available in health food stores, pharmacies or by mail order. They are not approved by the Food and Drug Administration which means, of course, that you don’t have the government’s assurance that the products really work and are safe.

Still, these alternative remedies are clearly setting America’s arthritic toes a-tappin’ and hands a-clappin’ – as they have in Europe for years in both oral and injectable versions. (The injectable form is not available here.)

At the Bread and Circus store in Cambridge, one combination product, Joint Fuel by Twin Laboratories, is selling “extremely well,” says acting assistant nutrition manager Catherine Devine. And another, marketed as Glucosamine Chondroitin Complex by the Solgar Vitamin and Herb Company, is sold out.

Glucosamine or chondroitin are selling well separately, too.

The only patented combination product is Cosamin, made by Nutramax Laboratories, Inc. in Baltimore, which also makes a nearly identical product, Cosequin, for animals. Like the health food products, Cosamin, which Nutramax may someday try to market as a drug, is a hot seller in pharmacies and doctors’ offices – $ 100 for a 60-day supply for a person under 200 pounds.

So far, there is not a single published study on the combination of glucosamine and chondroitin in humans, although several on Cosamin are in the works, says Dr. Todd Henderson, a veterinarian and vice president of Nutramax. Several studies of the combination product show promising results in animals.

But there are a number of European studies in people that suggest that, taken separately, glucosamine or chondroitin can help substantially. Glucosamine probably works by stimulating the cells that make cartilage, and chondroitin, by inhibiting cartilage breakdown.

Much of the fascination with these supplements has been triggered by the best-selling, if misleadingly-titled book, “The Arthritis Cure,” by Dr. Jason Theodosakis, a Tucson physician. Theodosakis says the osteoarthritis in his knees and one elbow was so bad he was on crutches and “couldn’t even brush my teeth.”

Despite surgery, he was convinced he would never live without pain and stiffness, despite high doses of anti-inflammatory drugs. But within two weeks of taking the dietary supplements, he says, he began experiencing a “dramatic recovery.”

Since then, he says he’s treated hundreds of people, though he sounds slightly chagrined at having used the word “cure” in his title, which the American College of Rheumatology calls “irresponsible” and the Arthritis Foundation, “deceptive.”

In an interview and in the book, Theodosakis is more cautious, saying he needed ” a catchy title” and that he’s talking about curing symptoms, not the disease itself.

Others studying glucosamine and chondroitin are also trying to temper the growing public enthusiasm.

Dr. David Eisenberg, a self-described “open minded skeptic” and director of the center for alternative medicine research at Beth Israel Deaconess Medical Center, is intrigued but cautious, because people with arthritis are so eager to try anything that might help. Eisenberg is considering whether to conduct a study of sea cucumbers, a Chinese remedy for arthritis.

Dr. Amal Das, an orthopedic surgeon in Hendersonville, N.C. who does knee and hip replacement surgery, is already conducting a double-blind, placebo-controlled trial of Cosamin in 100 arthritis patients.

At regular intervals, patients complete a questionnaire assessing their pain, says Das, who has previously studied other medications to help patients avoid joint replacement surgery.

In Toronto, rheumatologist Houpt is also doing a double-blind study on 100 patients, though he is testing glucosamine alone, not the combination product. He’s heard the promising anecdotes, but warns, “You have to have a balanced approach to this. That’s why it’s important to look at large populations.”

Hungerford, the Johns Hopkins surgeon, agrees, adding it is “theoretically possible” that the supplements, if taken before cartilage is destroyed, could reduce the need for some of the 200,000 knee replacements and more than 200,000 hip replacements done every year.

“But in order for me and thousands of other physicians to become convinced that this is the recognized and preferred first line of treatment, double-blind, placebo-controlled, multi-centered trials need to be done,” he says.

And unless these studies are done and the FDA gives its blessing, there’s no way to be sure that what you buy will work and be safe, or even that the labels on the bottles will tell the truth. In fact, one study of nearly 30 glucosamine or chondroitin products found that several did not contain the doses specified.

“I can’t imagine there are real big safety problems,” says Dr. David Felson, a rheumatologist at Boston Medical Center. And the FDA says it has received no complaints about either dietary supplement.

But Felson warns, “You don’t know what else might be in the stuff that you buy in the health food store.”

If you do decide to treat yourself, the dose Theodosakis suggests is 1,500 milligrams of glucosamine and 1,200 milligrams of chondroitin sulfate per day for a person who weighs between 120 and 200 pounds.

Three tablets of Cosamin provides that dosage. Each tablet also contains 66 milligrams of ascorbate and 10 milligrams of manganese to enhance absorption. But other combination products may not meet this suggested dose. Each table of Joint Fuel, for instance, contains only half as much glucosamine and only a tiny bit, 17 milligrams, of chondroitin.

If you want to try the supplements, you should definitely talk it over with your doctor, among other things, to confirm that you really do have arthritis and not some other problem.

But the bottom line, says Das of North Carolina, is that it’s “probably okay” to try the supplements, especially since “there are no known side effects.”

The risks, in other words, are all yours. But the benefits may be, too.

The rush is now on to Echinacea

March 17, 1997 by Judy Foreman

The Cheyenne used it for sore gums, the Comanches, for toothaches and sore throats. Other Native Americans kept it on hand for snakebites or syphilis.

Modern Americans seem to love the stuff, too, even if we can’t pronounce it. In fact, echinacea – that’s eck-in-EH-shia – is now the top selling herbal remedy in health food stores, though garlic and ginseng claim top honors in overall sales.

Unlike many medicinal herbs, this daisy-like flower, also known as purple coneflower, quite literally has its roots in America, not Asia. And compared to many plant medicines, there’s a fair amount of research on it – 350 studies by some counts.

Some people swallow the nasty-tasting liquid form of echinacea or sip it as tea at the first sign of a cold or flu. Others use it as a salve on burns or wounds that won’t heal. Others gargle it for strep throats or take it, internally and externally, for herpes. Some even give it, in small doses, to their kids.

But at $ 10 to $ 20 a bottle for the liquid stuff – depending on how much you use, a bottle may last three weeks – should we?

The answer, say many pharmacognocists, or scholars of medicinal herbs, is a hearty “why not?” It appears safe for many people and may, as advertised, stimulate the immune system. If you’re allergic to ragweed, though, or have HIV/AIDS or an autoimmune disease like lupus or multiple sclerosis, you should probably give it a miss.

While some of the research on echinacea may still not meet rigorous scientific standards, researchers in Germany – where doctors prescribed echinacea 2.5 million times in 1994 alone – have come up with provocative findings in recent years.

In one double-blind, placebo-controlled study of 180 volunteers, a German team found in 1992 that high doses of an alcohol-based extract of Echinacea purpurea root seemed to reduce the severity and duration of cold and flu symptoms.

But the dose appeared to be crucial. People who took 900 milligrams (or 180 drops) a day showed significant improvement. Those who took half that were no better off than people given a placebo, or dummy drug.

In another 1992 double-blind, placebo-controlled study of 108 people with chronic upper respiratory infections, those given 4 milliters of E. purpurea in liquid form twice a day for eight weeks had fewer infections than those taking a placebo.

In 1994, another German researcher reviewed 26 controlled human studies. Together, he concluded, the studies suggest that echinacea can stimulate the immune system.

But caveats are in order. The studies involved three types of echinacea, as well as combinations of types, and the quality of some studies was low, warns Steven Foster, an Arkansas plant photographer who writes on herbal research for the American Botanical Council, a research and educational group.

While echinacea does not kill bacteria, research suggests it does increase the number of white blood cells, as well as the process of phagocytosis, or the gobbling up of invading organisms by immune cells. It may also block an enzyme that helps infections spread.

There’s some evidence that echinacea also stimulates cells called fibroblasts, which play a role in healing wounds, says Cathy Crandall, a researcher of medicinal plants at Washington University in St. Louis.

The problem, though, says Dr. Jerome Groopman, an immunologist and chief of experimental medicine at Beth Israel Deaconess Medical Center, is that “you’re kind of poking in a black box.”

Lots of natural products stimulate some parts of the immune system, he says, but what’s needed is a “rigorous evalution” of echinacea and other herbs.

Still, those who do study herbs seriously, among them Gail Mahady, a pharmacognocist at the University of Illinois in Chicago, say the data on echinacea are a lot more solid than that on some herbal remedies.

“I don’t think anyone could look through the literature and honestly say echinacea doesn’t stimulate the immune system,” she says.

Echinacea “is one of the few herbs I take,” adds Varro Tyler, who has studied dozens of herbs and is professor of pharmacognosy emeritus at Purdue University.

So far, no one is sure which of echinacea’s constituents might account for such effects, though there’s some evidence that one component, high molecular weight polysaccharides, can activate cells that gobble up invading germs.

A more pressing question, for most consumers, is which kind of echinacea – E. angustifolia, E. pallida or E. purpurea – to take, and in what formulation.

Most of the research has been done on E. purpurea, and it is this type of echinacea that the German Commission E, the leading authority on herbal remedies, recommends for colds and respiratory infections and for urinary tract infections as well.

The Germans endorse the above-ground parts of E. purpurea – not the roots – taken either as pressed juice in an alcohol solution or as an injection. (Injections of echinacea are not available in this country, though they are in Germany.)

There has been less study of E. angustifolia, notes Tyler, though he thinks the roots of this form may actually be the best product. In practice, many of the dozens of echinacea products sold in America are combinations of all three types.

If you do take a combination product, says Mahady of Chicago, try to get one that contains the above-ground parts of E. purpurea and the roots of E. angustifolia and E. pallida. Some products give this information on the label.

Mahady takes the stuff herself – the 22 percent liquid formulation, not the capsules – whenever she feels a cold coming on. “It tastes terrible,” she says, but seems to help.

And if you take echinacea, the German Commission suggests, stop before eight weeks because it loses effectiveness over time.

Dr. Carol Englender, a Newton physician who also uses herbal remedies, says she recommends echinacea often. “Just today, I told four people to take it for the rest of the winter,” she said recently. “It’s good stuff.”

And while some think echinacea in an alcohol solution works best, Englender believes the capsules are effective, too.

Dr. Edward Chapman, another Newton physician who recommends echinacea to patients, adds that “the nice thing is it’s safe, and you can use if for kids.”

For adults, he says, the usual recommendation is 90 drops a day – you quickly learn how to gauge how many drops are in a dropperful – spread over three doses. Manufacturers – backed by German research – often recommend as much as 150 drops a day. For small children, Chapman says, 10 drops a day often help, and for kids between 5 and 10 years of age, 20 drops.

But the bottom line, says Arkansas herbalist Foster, is that when it comes to choosing the best dose and a formulation, “what we don’t know is greater than what we do know.”

Fuzzy thinking about herbs

Despite the booming popularity of herbal remedies among consumers, a number of myths remain, perhaps the silliest of which is the idea that anything “natural” must be safe and anything synthetic, dangerous.

But mushy thinking among fans of herbal medicine often goes further than that, verging on what Varro Tyler, an herb scholar and professor of pharmacognosy emeritus at Purdue University, calls “paraherbalism,” a belief in the superiority of anything natural and organic.

Other tenets of paraherbalism, which Tyler discusses in his 1994 book, “Herbs of Choice,” include these beliefs:

  • There is a conspiracy by the medical establishment to discourage the use of herbs. Wrong, says Tyler. It’s just that doctors know little about herbs because medical schools don’t teach them and pharmaceutical firms don’t bother studying herbs because they see no profit in doing so.

  • Herbs cannot harm, only cure. Wrong again. Some highly toxic substances, including the amatoxins, strychnine, ricin and many others are derived from plants.

  • Whole herbs are more effective than their components. For every example that supports this, says Tyler, there’s another that contradicts it, because many herbs also contain toxins.

  • Reducing the dose of a medicine increases its efficacy.  This is a central tenet of homeopathy, an enterprise philosopically different from herbal medicine. Many scientists, Tyler among them, think homeopathy makes no sense.

  • Herbs were created by God specifically to cure disease. “This thesis,” as Tyler puts it, “is not testable and should not be used as a substitute for scientific evidence.”

Ginseng $350 million for not much

February 3, 1997 by Judy Foreman

Ginseng has become the tonic of choice for tired Americans.

Thinking it will make us better athletes or reduce our stress or just get us through the night shift, we now spend $ 350-to-$ 400 million a year on the stuff, making ginseng second only to garlic as the nation’s most sought-after herbal remedy.

In fact, ginseng is a major reason why the herbal industry is doing so well – $ 1.5 billion a year in sales – just as herbals are a big reason for the blooming health of the $ 6 billion a year dietary supplement industry.

But what’s truly astounding about all this is how little we know about ginseng.

Did you know, for instance, that there are at least three different products that Americans call ginseng?

There’s Panax ginseng, which is grown in Asia and gobbled up by Americans because it’s relatively cheap (about $ 15 for a two-month supply) and because Americans are relatively clueless about ginseng, compared to the Chinese with thousands of years of hands-on experience.

There’s American ginseng or Panax quinquefolius, which grows wild in Appalachia (free-lance pickers get $ 500 a pound for it) and in Canada. It is sold mostly in China, where it is touted inaccurately as an aphrodisiac and for its supposed cooling effect in tropical weather.

“Americans send their ginseng to China, they send theirs to us,” laughs herbal industry analyst Matthew Patsky of Adams, Harkness & Hill in Boston. “It doesn’t make any sense.” In Chinatown, he adds, there’s even “American ginseng that will have been shipped to China. . .and back to us!”

And then there’s so-called Siberian ginseng, which is so different, chemically and botanically, from the first two that it should be called by its real name, Eleutherococcus senticosus, or eleuthero.

Most of the studies, such as they are – and they range from passable to not-worth-looking-at – have been done on Panax ginseng, the Asian stuff, though a big problem in ginseng research generally is that researchers often don’t know which type they are studying.

“There is no good clinical data for American ginseng,” says Gail Mahady co-author of a forthcoming review for the World Health Organization and a PhD pharmacognocist, or scholar of medicinal herbs, at the University of Illinois in Chicago. There was one good study, she says, but it showed no effect.

In the test tube, though, there have been some encouraging results with American ginseng. Dr. Rosemary Duda, for instance, a surgical oncologist at Beth Israel Deaconess Medical Center, has found it inhibits growth of breast and prostate cancer cells.

There is somewhat more data on eleuthero in humans, Mahady says, but that research, too, “is not very good. Most studies were done in Russia in the Sixties.”

Those studies often involved pilots, says Walter Lewis, a professor of biology at Washington University and senior botanist at the Missouri Botanical Garden. They took the stuff, they went up, they flew, they “got down and said they had a great flight. It was not a controlled situation.”

“But they felt strongly about this and they may be right – it’s just that we haven’t got the experiments that test this,” says Lewis, who believes that ginseng “remains a medical mystery with no proven efficacy for humans.”

Varro Tyler, professor of pharmacognosy emeritus at Purdue University, says “although some data suggest eleuthero may enhance performance, on the basis of existing evidence, its consumption as a tonic/adaptogen cannot now be recommended.”

In the parlance of alternative medicine, an “adaptogen” is a substance believed to help people cope with stress.

But what of Panax ginseng, the herb that the Chinese have gulped happily for millennia and Americans now consume in teas, capsules, extracts and, sometimes, as dried root – which, for the really exotic stuff, can cost thousands of dollars.

“It’s selling very well, and I think the reason is people are looking for more energy,” says Marilyn Dale, nutrition team leader at the Bread & Circus supermarket chain. “It’s amazing to me that so many people know about it.”

The Asian herb is chemically complicated, says Tyler, and some of its constituents have biological effects that are directly opposite to others. One component acts as a central nervous system sedative, another as a stimulant, notes the American Botanical Council, a nonprofit herbal research and educational organization in Texas.

In hundreds of animal studies, Asian ginseng has been shown to act as a kind of general tonic – prolonging the time animals can swim, preventing stress-induced ulcers and boosting immune system activity.

Data presented last week at a conference in Washington, D.C., by the manufacturer of Ginsana, the best-selling ginseng in the United States, suggest it also improves oxygen utilization, decreases buildup of lactic acid in athletes and may boost immunity.

Still, cautions Tyler, “we are still almost totally ignorant of Panax ginseng’s effects on human beings, insofar as results obtained from appropriate clinical studies are concerned.”

Mahady of Chicago agrees that “most of the clinical studies have poor methodology, no proper controls and usually no standardization of what ginseng products are used.” Still, she says, if those weak studies are lumped with test tube and animal experiments, “you can easily say ginseng can be used as a restorative agent to enhance mental and physical state.”

Ara DerMarderosian, a pharmacognocist at the Philadelphia College of Pharmacy and Science, agrees ginseng may help with adaptation to stress and with endurance, but he, too, warns about the poor quality of studies from other countries.

But if it’s not clear yet whether or how much ginseng will help you, it is clear that it probably won’t hurt you, as long as you don’t have diabetes or high blood pressure or consume too much caffeine while you’re taking it, Mahady says.

Asian ginseng can raise blood pressure and stimulate release of insulin from the pancreas, which could lower blood sugar too rapidly in some diabetics.

Ginseng can also cause adverse side effects in people taking antidepressants called monoamine oxidase inhibitors, and may cause insomnia, diarrhea and skin eruptions.

For all that, though, the German “Commission E” monographs, regarded as the world’s best compilation of data on herbal remedies, conclude there are no known side effects of ginseng, and the WHO analysis concurs.

Still, because there is little government regulation of herbs – the Food and Drug Administration does not conduct pre-market reviews, as it does for drugs – the role of herb cop has fallen to the industry itself.

Perhaps the most extensive effort is a detailed analysis of roughly 400 ginseng products on the US market by the American Botanical Council, due out this summer.

Council chief Mark Blumenthal says previous studies have shown that some ginseng products did not contain the kind or amount of ginseng stated on the label. The council study, so far, shows that more than 50 percent of the products are accurately labelled. When the research, which is funded by the herb industry, is published, the ABC will name brands that flunk the tests.

So should you spend your money on ginseng?

Tyler puts it this way: “If it really worked as an enhancer of athletic performance and endurance, the Olympic committee would ban it.” So far, he notes, the committee has not.

But unless you have high blood pressure, diabetes or some other reason to steer clear of it, the usual dose – 1 to 2 grams as dried root or capsules, or 100 to 200 milligrams of extract a day – probably won’t hurt you.

At the very least, says biologist Lewis, you can probably count on the good old placebo effect: “If you go out and spend $ 10 and if you take it religiously, it has to have an effect on your mid and body as a whole.”

To learn more

To read more about herbs, including ginseng, you might try:

  • “The Honest Herbal,” by Varro Tyler. Pharmaceutical Products Press (Haworth Press), Binghamton, N.Y.

  • “Herbs of Choice,” by Varro Tyler. Pharmaceutical Products Press (Haworth Press), Binghamton, N.Y.

  • “Herbal Prescriptions for Better Health,” by Donald J. Brown. Prima Publishing, Rocklin, Calif.

  • “HerbalGram,” a quarterly publication of the American Botanical Council in Austin, Texas, available at 1-800-373-7105 or on the Web at www.herbalgram.org

  • “The Random House Book of Herbs,” by Roger Phillips and Nicky Foy. Random House, N.Y.

  • “HerbalGram,” a quarterly publication of the American Botanical Council in Austin, Texas.

Trying everything, more and more cancer patients seek out ancient Chinese remedies to augment modern medicine

April 1, 1996 by Judy Foreman

For Ingrid Schorr, 36, an actor and writer who lives in Arlington, the bomb dropped last September: a totally unexpected diagnosis of breast cancer.

The diagnosis was traumatic enough, she says, but she also felt “desperate and sad” about having to undergo chemotherapy. She knew it would leave her weak and drained.

Her instincts were clear. She agreed to fight cancer with the harsh tools of Western medicine, the so-called “slash, burn and poison” approach of surgery, radiation and chemo.

But she also vowed to try to protect her body against that onslaught with what she hoped would be the gentler, more supportive tools of ancient herbs and modern nutrition as well.

And she didn’t want some do-it-yourself, East-meets-West patchwork of ideas culled from books, friends and herbalists who didn’t consult with oncologists. What she wanted, she says, was “a complete program of nutritional support and detoxification with herbs, and I wanted it from an oncologist.”

That proved a tall order, at least in this medical mecca.

So Schorr commutes monthly to Evanston, Ill., where she sees Dr. Keith Block, an internist who has put together a staff of oncologists, herbal chemists, dieticians and others who offer a combined program of chemotherapy, herbs, diet, psychological support, exercise and stress management.

Schorr may be unusual in the lengths to which she went to find a good blend of Eastern and Western medicine. But her inclination to augment – not replace – Western medicine with reputable alternatives is anything but unusual.

Cancer patients today, like AIDS patients a decade ago, are pushing outside the traditional frontiers of medicine, demanding that doctors take seriously their desire to combine Western medicine with other remedies, especially medicinal herbs used for millenia in China.

To be sure, even Block warns that there is more art than science in blending of the two traditions.

“There simply haven’t been enough carefully-controlled human studies to know how much good many of these traditional herbs can do,” he says. “But most of evidence to date, which is admittedly anecdotal, suggests there is little to no harm in herbs prescribed by practitioners who know what they’re doing.”

Good, bad or indifferent, herbs are clearly in demand.

“In the past, doctors would have tried to discourage patients from using anything alternative while undergoing cancer treatment. But today, you don’t see discouragement. You see some indifference and some interest,” says Alexandra Todd, a Suffolk University medical sociologist. That’s “because the public is doing it, not because the medical profession wants to.”

Indeed, many cancer patients do not tell their oncologists when they take herbs on the side, though they should. But “the more you ask, the more you find out that people do it,” adds Dr. Karen Krag, an oncologist at the Dana Farber Cancer Institute. “There’s more of it out there than oncologists would like to believe.”

And although Americans don’t equal the Germans, the leaders among Western nations in using and studying herbs, we now spend $ 2 billion on them yearly, and the market is growing 20 to 30 percent a year, says Mark Blumenthal, executive director of the American Botanical Council, a nonprofit research group.

“Business is booming,” adds acupuncturist-herbalist Michael Broffman of the Pine Street Chinese Benevolent Association in San Anselmo, Calif.

“When we first came to Marin County in 1983, there were only three of us practicing Chinese medicine. Now there are 100 in this county alone, and about 6,000 nationwide,” says Broffman, a leader in the art of trying to tailor herb use to the various types and stages of standard chemotherapy.

It is no easy task.

There are dozens of types of cancers, thousands of herbs and thousands upon thousands of herbal combinations. Patients also vary in gender, age, stage of disease and susceptibility to the effects – good and bad – of herbs. And, practitioners say, an herb that seems to work at one stage – such as in the middle of chemotherapy – may be useless when the patient is in remission.

For example, one chemotherapy regimen often used for breast cancer is CMF – cytoxan, methotrexate and 5-fluorouracil. To go with this regimen, Broffman often uses herbs like astragalus and a Japanese formula called JT-48, JTT or Juzentaihoto.

But that’s just the beginning. Because CMF is given in 21-day cycles, some herbs are given on days 1 through 4, in hopes they will enhance circulation and boost the effects of chemo. Others are given on days 5 through 10, the idea being to clean up dead cells, and others on days 11 through 21, to build strength and immunity.

For other cancers, the recommended remedies are different. For non-Hodgkins’ lymphoma, Block uses the Chinese herb Dan Shen, also called red-rooted sage or salvia miltiorrhizaCQ, citing research suggesting that it can boost the remission rate of standard chemotherapy.

Because choosing the combination and timing of herbs is complicated – and because herbs can be toxic – herbalists stress that you should not fool around with self-medication. Chances are you won’t know what you’re doing.

The trouble is, you can’t be sure your herbalist knows, either.

“There is no quality control for herbalists,” says Blumenthal of the botanical council, though many herbalists are also acupuncturists, who often take training in herbal medicine.

Last year, the National Commission for the Certification of Acupuncture, which administers the national exam for acupuncturists, developed a separate exam in Chinese herbal medicine. Increasingly, many states, including Massachusetts, are beginning to demand that acupuncturusts show proof of training in herbs if they use herbs in their practice.

But the issue of training raises a deeper question: How solid is the research on herbal medicine to start with?

“I do believe that empirical observation by astute Chinese healers has identified active compounds over the past 3,000 years,” says Dr. Jerome Groopman, chief of hematology and oncology at Deaconess hospital.

But Groopman worries that sometimes “neither the herbalists nor the physicians really know what’s in these compounds.”

Beyond the question of what’s really in those funny little packages of twigs, dried flowers and curly, brown things is the question of research standards.

“Clinical trials in China are frequently not randomized controlled clinical trials,” warns Michael Lerner in his cautious book, “Choices in Healing.”

“And even when they are,” he writes, “the methodology is often suspect by Western scientific standards.”

There is quality control for herbs themselves, says Blumenthal, but it’s “variable from one company to another.”

So far, the US Food and Drug Administration has stayed on the sidelines. Legally, the FDA says, herbs are classed as dietary supplements and do not need its approval before they hit the market. Once a product is marketed, however, the FDA can have it removed if evidence accumulates that it is is dangerous.

All this, of course, leaves patients like Ingrid Schorr fending for themselves and eager for physicians like Dr. Keith Block.

“I get more than 50 calls a day from people looking for doctors who do what we do,” says Block, vice president the American Cancer Society chapter in Chicago and medical director of the cancer program at Edgewater Medical Center, a hospital affiliated with the University of Illinois School of Medicine. “As far as we know, we’re the only place in the country trying to put it all together, to combine the best of both worlds.”

Based on his early data – presented at a conference in 1994 and published in the proceedings of that meeting – Block thinks his individualized program “buys patients better odds.”

Ingrid Schorr hopes so, too, and so far things look good. Despite all the chemo, she has not lost her hair or her monthly periods. She also has a good appetite and has had little nausea.

Of even greater importance, she says, is her peace of mind.

“The main benefit I’ve had from finding a doctor who could put it all together for me is that I don’t feel so scrambled,” she says. “I was trying to do it all myself before and that was making me crazy.”

1 If you are considering herbs

  • If you want to take herbs while in the care of a mainstream doctor, there are several things you can do to bridge the gap between East and West.
  • The first is to get a list – in your own language – of all the herbs you are taking or that have been recommended. Give this list to your doctor and ask if he or she recognizes any of the herbs and knows of any ill effects.
  • You might also ask your doctor to keep your list on file and compare your experience on herbs with that of other patients. This may not help you directly, but it can lead to the slow accumulation of anecdotal evidence that, with further research, can become genuine science.
  • This approach has already helped boost knowledge of alternative remedies for AIDS, says Dr. Calvin Cohen, research director for the Brookline-based Community Research Initiative. Through CRI, 700 Boston-area patients with AIDS or HIV have joined a Canadian-American study of 15,000 patients aimed at keeping track of how patients fare on alternative treatments.
  • “This is not a prospective study, but it is a first step,” he says. “Unless we start to acknowledge these anecdotes, people get cynical. They think doctors don’t care.”

 2 Licensing herbalists

  • At the moment, there is no licensing of herbalists in Massachusetts, which means that anyone can hang up a shingle and hand out herbs.
  • But there are ways to protect yourself, and the best is probably to find a licensed acupunturist who has been trained in using herbs, as many have. Acupuncuturists are licensed – by the committee on acupuncture of the state Board of Registration in Medicine.
  • Beginning in January 1998, acupuncturists who use herbs will have to submit evidence that they have been trained in herb use in a nationally accredited program in acupuncture and Oriental medicine, or an equivalent state-approved program.
  • To learn if your acupuncturist is licensed and is trained in herbs, call 727-3086 ext. 363 on Wednesdays, 2-4 p.m., and Thursdays and Fridays, 9 a.m.-4 p.m..

3 For more information

For more information, you might read:

  • “Choices in Healing,” by Michael Lerner; MIT Press, Cambridge.
  • “Double Vision,” by Alexandra Todd; University Press of New England, Hanover, N.H.
  • “Herbs of Choice: The therapeutic use of phytomedicinals,” by Varro E. Tyler; The Haworth Press, Inc., Binghamton, N.Y.
  • “HerbalGram,” a quarterly journal of the American Botanical Council. For a ($ 25) year’s subscription, send name, address and check or credit card number to P.O. Box 201660, Austin, Tex. 78720.

For general information on alternative therapies, call:

  • Commonweal, a research and environmental research institute in Bolinas, California, 415-868-0970.

For information on finding herbalists, call:

  • National Holistic Health Directory & Resource Guide, 1995-1996. No referrals by phone, but guide lists practitioners by specialty and region. Call 800-782-7006 for the $ 5.95 guide. The guide is also available at newstands and online at: http://www.spdcc.com/home/newage
  • Herbal treatments are available through the teaching clinic of New England School of Acupuncture, 617-926-4271.

« Previous Page
Next Page »

Copyright © 2025 Judy Foreman